For most of the year, the picture looked like this: Of course, the review cycle is long drawn, especially in markets such as Canada, where we have not seen a single generic GLP being approved, including liraglutide, which has not been approved by Health Canada. Siddharth Mittal, CEO & MD, Biocon | Q3 FY26 The export bet has a cleaner economic logic than the domestic one
As of April 22, 2025, New Yorks law on underage supplements is now in effect
Drugs Targeting p53 mutations with FDA approval and in clinical trials
Our genomic analysis showed a near absence of GSH system in these organisms [Additional file 1
Find a lower online price at a major Canadian competitor and we will beat the price by 1
These findings were not attributed to variations in food intake, which implies that the observed results were mediated by alterations in metabolic processes [1]